TACSTD2 and hepatocellular carcinoma: Thus, we studied the phosphorylation status of TACSTD2 in hepatoma cells by immunoprecipitation with anti-TACSTD2 antibody followed by deglycosylation and Western blot analysis using a PKC substrate-specific antibody.